Jinshi Data News on March 12th, some investors asked, ‘The risk reminder issued by the company a few days ago stated that there have been no major events such as mergers and acquisitions of general robots, etc. Recently, there have been rumors on the internet that Lianfeng Health’s Chairman Liao and his team visited Fourier Intelligence for guidance and exchange. Is this rumor true?’ In response to this, Lianfeng Health stated that the mentioned online rumors are purely false. Please invest rationally and be cautious of risks. As a listed company on the A-share market, Lianfeng Health actively fulfills the obligation of information disclosure for listed companies in accordance with relevant laws and regulations, adhering to the principles of truthfulness, accuracy, completeness, timeliness, and fairness to protect the legitimate rights and interests of investors. For major information related to the company, please refer to the official announcements published by the company in designated disclosure media.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Xinlong Health: The online rumors are purely false, please invest rationally.
Jinshi Data News on March 12th, some investors asked, ‘The risk reminder issued by the company a few days ago stated that there have been no major events such as mergers and acquisitions of general robots, etc. Recently, there have been rumors on the internet that Lianfeng Health’s Chairman Liao and his team visited Fourier Intelligence for guidance and exchange. Is this rumor true?’ In response to this, Lianfeng Health stated that the mentioned online rumors are purely false. Please invest rationally and be cautious of risks. As a listed company on the A-share market, Lianfeng Health actively fulfills the obligation of information disclosure for listed companies in accordance with relevant laws and regulations, adhering to the principles of truthfulness, accuracy, completeness, timeliness, and fairness to protect the legitimate rights and interests of investors. For major information related to the company, please refer to the official announcements published by the company in designated disclosure media.